Addressing the Challenges of Next-Generation Antibody-Drug Conjugate Medicines

04th April 2022

Access and leverage deep industry knowledge into some of the key strategies in support appropriate target product profiling for the development of next-generation antibody-drug conjugates (ADCs).

Access the full on-demand webinar from our team of industry experts as they take an in-depth look at their area of specialism.